Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Open Access
- 9 May 2021
- journal article
- research article
- Published by Elsevier BV in Cell Reports Medicine
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council
This publication has 50 references indexed in Scilit:
- Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protectionJCI Insight, 2016
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo ActivityCell, 2014
- Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirusVirology, 2014
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- The Direction of Plasma Membrane Exchange between Lymphocytes and Accessory Cells by Trogocytosis Is Influenced by the Nature of the Accessory CellThe Journal of Immunology, 2010
- Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to Cancer Cells Promotes Trogocytosis Mediated by THP-1 Cells and MonocytesThe Journal of Immunology, 2008
- Atypical Measles and Enhanced Respiratory Syncytial Virus Disease (ERD) Made SimplePediatric Research, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Fc Receptor γ Chain Residues at the Interface of the Cytoplasmic and Transmembrane Domains Affect Association with FcαRI, Surface Expression, and FunctionOnline Journal of Public Health Informatics, 2004
- A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus DiseaseThe Journal of Experimental Medicine, 2002